ClinicalTrials.Veeva

Menu
C

CAP Research | Quatre Bornes, Mauritius

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

M5049
ALG-000184
IVA337

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 4 total trials

A Study of ALG-000184 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Healthy Volunteers and CHB Subjects

A Randomized Study of ALG-000184 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Heal...

Enrolling
Chronic Hepatitis B
Drug: Placebo
Drug: ALG-000184

The purpose of the study is to evaluate the long term safety and efficacy of orally administered M5049 in participants with subacute cutaneous lupus...

Enrolling
Systemic Lupus Erythematosus
Drug: M5049 medium dose
Drug: M5049 low dose

Trial sponsors

A
I
Merck KGaA (EMD Serono) logo
Merck KGaA (EMD Serono) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems